Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

RBC Capital Maintains Sector Perform on Acceleron Pharma, Raises Price Target to $179

RBC Capital analyst Kennen MacKay maintains Acceleron Pharma (NASDAQ:XLRN) with a Sector Perform and raises the price target from $113 to $179.
byBenzinga Newsdesk
September 27, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

RBC Capital analyst Kennen MacKay maintains Acceleron Pharma (NASDAQ:XLRN) with a Sector Perform and raises the price target from $113 to $179.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts